elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Pemetrexed
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Pemetrexed
RIS
0.002
(Research Intensity Score)
Papers
241
Top papers
Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
2023 · 737 citations
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non–Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study
2023 · 723 citations
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer
2024 · 151 citations
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2023 · 270 citations
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
2025 · 77 citations
Newest papers
Model‐Based Meta‐Analysis of Overall Survival in Vulnerable Platinum‐Ineligible NSCLC Populations
2026 · 3 citations
Sunvozertinib monotherapy versus platinum-based chemotherapy as first-line treatment for advanced NSCLC with EGFR exon20ins: Primary analysis of a multinational phase 3 randomized study (WU-KONG28).
2026 · 2 citations
Editorial: Immunotherapeutic advances in brain tumours
2026
Occult lung adenocarcinoma diagnosed by EBUS-TBNA after pneumothorax resolution in an RA-ILD patient with respiratory failure
2026
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
2025 · 77 citations
A sample from the 100 top papers behind Pemetrexed.
Create a free account to browse them all →
Pemetrexed's history
Research intensity over time
Explore Pemetrexed's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Pemetrexed's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link